Publications scientifiques en hépatologie
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.
2019
Lancet HIV.
Stanley TL, Fourman LT, Feldpausch M, et al.
6(12):e821-e830.
Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.
2014
JAMA.
Stanley TL, Feldpausch M, Oh J, et al.
312(4):380-389.
The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.
2014
J Clin Endocrinol Metab.
Makimura H, Murphy CA, Feldpausch MN, Grinspoon SK.
99(1):338-343. Epub 2013 Dec 20.
Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging.
2013
JAMA Neurol.
Friedman SD, Baker LD, Borson S, et al.
70(7):883-80.
Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.
2012
J Clin Endocrinol Metab.
Makimura H, Feldpausch MN, Rope AM, et al.
97(12):4769-4779.